One step forward, three steps back for Ferring's prostate cancer drug in UK
This article was originally published in Scrip
Executive Summary
Bayer Healthcare's Xofigo (radium-223 dichloride) is in but Ferring Pharmaceutical's Firmigon (degarelix) is out according to the latest draft guidance from the UK's health technology appraisal body NICE.